Abstract
Background
The use of rosemary (Rosmarinus officinalis) leaves and their constituents as a source of dietary antioxidants and flavoring agents is continuously growing. Carnosol and carnosic acid, two major components of rosemary extracts, have shown activity for cancer prevention and therapy.
Aim of the study
In this study, we investigate the cytotoxic and anti-angiogenic activities of carnosol and carnosic acid, in order to get further insight into their mechanism of action.
Results
Our results demonstrate that the mentioned diterpenes inhibit certain functions of endothelial cells, namely, differentiation, proliferation, migration and proteolytic capability. Our data indicate that their growth inhibitory effect, exerted on proliferative endothelial and tumor cells, could be due to, at least in part, an induction of apoptosis. Inhibition of the mentioned essential steps of in vitro angiogenesis agrees with the observed inhibition of the in vivo angiogenesis, substantiated by using the chick chorioallantoic membrane assay.
Conclusions
The anti-angiogenic activity of carnosol and carnosic acid could contribute to the chemopreventive, antitumoral and antimetastatic activities of rosemary extracts and suggests their potential in the treatment of other angiogenesis-related malignancies.
Similar content being viewed by others
References
Commission Directive (2010) 2010/67/EU of 20 October 2010 amending Directive 2008/84/EC laying down specific purity criteria on food additives other than colours and sweeteners. Off J Eur Union L277:17–26
Commission Directive (2010) 2010/69/EU of 22 October 2010 amending the Annexes to European Parliament and Council Directive 95/2/EC on food additives other than colours and sweeteners. Off J Eur Union L279:22–31
Moss M, Cook J, Wesnes K, Duckett P (2003) Aromas of rosemary and lavender essential oils differentially affect cognition and mood in healthy adults. Int J Neurosci 113:15–38
Kelsey NA, Wilkins HM, Linseman DA (2010) Nutraceutical antioxidants as novel neuroprotective agents. Molecules 15:7792–7814
Yesil Celiktas O, Hames Kocabas EE, Bedir E, Vardar Sukan F, Ozekc T, Baser KHC (2007) Antimicrobial activities of methanol extracts and essential oils of Rosmarinus officinalis, depending on location and seasonal variations. Food Chem 100:553–559
Moreno S, Scheyer T, Romano CS, Vojnov AA (2006) Antioxidant and antimicrobial activities of rosemary extracts linked to their polyphenol composition. Free Radic Res 40:223–231
Takaki I, Bersani-Amado LE, Vendruscolo A, Sartoretto SM, Diniz SP, Bersani-Amado CA, Cuman RK (2008) Anti-inflammatory and antinociceptive effects of Rosmarinus officinalis L. essential oil in experimental animal models. J Med Food 11:741–746
Vitaglione P, Morisco F, Caporaso N, Fogliano V (2004) Dietary antioxidant compounds and liver health. Crit Rev Food Sci Nutr 44:575–586
Huang MT, Ho CT, Wang ZY, Ferraro T, Lou YR, Stauber K et al (1994) Inhibition of skin tumorigenesis by rosemary and its constituents carnosol and ursolic acid. Cancer Res 54:701–708
Cheung S, Tai J (2007) Anti-proliferative and antioxidant properties of rosemary Rosmarinus officinalis. Oncol Rep 17:1525–1531
Russo A, Lombardo L, Troncoso N, Garbarino J, Cardile V (2009) Rosmarinus officinalis extract inhibits human melanoma cell growth. Nat Prod Commun 4:1707–1710
Yesil-Celiktas O, Sevimli C, Bedir E, Vardar-Sukan F (2010) Inhibitory effects of rosemary extracts, carnosic acid and rosmarinic acid on the growth of various human cancer cell lines. Plant Foods Hum Nutr 65:158–163
Yi W, Wetzstein HY (2011) Anti-tumorigenic activity of five culinary and medicinal herbs grown under greenhouse conditions and their combination effects. J Sci Food Agric 91:1849–1854
Mulinacci N, Innocenti M, Bellumori M, Giaccherini C, Martini V, Michelozzi M (2011) Storage method, drying processes and extraction procedures strongly affect the phenolic fraction of rosemary leaves: an HPLC/DAD/MS study. Talanta 85:167–176
Aruoma OI, Halliwell B, Aeschbach R, Löligers J (1992) Antioxidant and pro-oxidant properties of active rosemary constituents: carnosol and carnosic acid. Xenobiotica 22:257–268
Poeckel D, Greiner C, Verhoff M, Rau O, Tausch L, Hörnig C et al (2008) Carnosic acid and carnosol potently inhibit human 5-lipoxygenase and suppress pro-inflammatory responses of stimulated human polymorphonuclear leukocytes. Biochem Pharmacol 76:91–97
Bai N, He K, Roller M, Lai CS, Shao X, Pan MH, Ho CT (2010) Flavonoids and phenolic compounds from Rosmarinus officinalis. J Agric Food Chem 58:5363–5367
Bernardes WA, Lucarini R, Tozatti MG, Souza MG, Silva ML, Filho AA et al (2010) Antimicrobial activity of Rosmarinus officinalis against oral pathogens: relevance of carnosic acid and carnosol. Chem Biodivers 7:1835–1840
Wang T, Takikawa Y, Satoh T, Yoshioka Y, Kosaka K, Tatemichi Y, Suzuki K (2011) Carnosic acid prevents obesity and hepatic steatosis in ob/ob mice. Hepatol Res 41:87–92
Lee JJ, Jin YR, Lee JH, Yu JY, Han XH, Oh KW et al (2007) Antiplatelet activity of carnosic acid, a phenolic diterpene from Rosmarinus officinalis. Planta Med 73:121–127
Nabekura T, Yamaki T, Hiroi T, Ueno K, Kitagawa S (2010) Inhibition of anticancer drug efflux transporter P-glycoprotein by rosemary phytochemicals. Pharmacol Res 61:259–263
Yu YM, Lin CH, Chan HC, Tsai HD (2009) Carnosic acid reduces cytokine-induced adhesion molecules expression and monocyte adhesion to endothelial cells. Eur J Nutr 48:101–106
Johnson JJ (2011) Carnosol: a promising anti-cancer and anti-inflammatory agent. Cancer Lett 305:1–7
Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438:932–936
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Quesada AR, Medina MA, Muñoz-Chápuli R, Ponce AL (2010) Do not say ever never more: the ins and outs of antiangiogenic therapies. Curr Pharm Des 16:3932–3957
Quesada AR, Medina MA, Alba E (2007) Playing only one instrument may be not enough: limitations and future of the antiangiogenic treatment of cancer. Bioessays 29:1159–1168
Carmeliet P, Jain RK (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature 473:298–307
Quesada AR, Muñoz-Chápuli R, Medina MA (2006) Anti-angiogenic drugs: from bench to clinical trials. Med Res Rev 26:483–530
Rodríguez-Nieto S, González-Iriarte M, Carmona R, Muñoz-Chápuli R, Medina MA, Quesada AR (2002) Anti-angiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge. FASEB J 16:261–263
Castro ME, González-Iriarte M, Barrero AF, Salvador-Tormo N, Muñoz-Chápuli R, Medina MA, Quesada AR (2004) Study of puupehenone and related compounds as inhibitors of angiogenesis. Int J Cancer 110:31–38
Martínez-Poveda B, Quesada AR, Medina MA (2005) Hyperforin, a bio-active compound of St. John’s Wort, is a new inhibitor of angiogenesis targeting several key steps of the process. Int J Cancer 117:775–780
Cárdenas C, Quesada AR, Medina MA (2006) Evaluation of the anti-angiogenic effect of aloe-emodin. Cell Mol Life Sci 63:3083–3089
García-Caballero M, Marí-Beffa M, Medina MÁ, Quesada AR (2011) Dimethylfumarate inhibits angiogenesis in vitro and in vivo: a possible role for its antipsoriatic effect? J Invest Dermatol 131:1347–1355
Kubota Y, Kleinman HK, Martin GR, Lawley TJ (1988) Role of laminin and basement membrane in the morphological differentiation of human endothelial cells into capillary-like structures. J Cell Biol 107:1589–1598
Mosmann T (1983) Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 65:55–63
Syed DN, Khan N, Afaq F, Mukhtar H (2007) Chemoprevention of prostate cancer through dietary agents: progress and promise. Cancer Epidemiol Biomarkers Prev 16:2193–2203
Johnson JJ, Syed DN, Heren CR, Suh Y, Adhami VM, Mukhtar H (2008) Carnosol, a dietary diterpene, displays growth inhibitory effects in human prostate cancer PC3 cells leading to G2-phase cell cycle arrest and targets the 5′-AMP-activated protein kinase (AMPK) pathway. Pharm Res 25:2125–2134
Pan MH, Lai CS, Wu JC, Ho CT (2011) Molecular mechanisms for chemoprevention of colorectal cancer by natural dietary compounds. Mol Nutr Food Res 55:32–45
Fresco P, Borges F, Diniz C, Marques MP (2006) New insights on the anticancer properties of dietary polyphenols. Med Res Rev 26:747–766
Dörrie J, Sapala K, Zunino SJ (2001) Carnosol-induced apoptosis and downregulation of Bcl-2 in B-lineage leukemia cells. Cancer Lett 170:33–39
Pesakhov S, Khanin M, Studzinski GP, Danilenko M (2010) Distinct combinatorial effects of the plant polyphenols curcumin, carnosic acid, and silibinin on proliferation and apoptosis in acute myeloid leukemia cells. Nutr Cancer 62:811–824
Bröker LE, Kruyt FA, Giaccone G (2005) Cell death independent of caspases: a review. Clin Cancer Res 11:3155–3162
Constantinou C, Papas KA, Constantinou AI (2009) Caspase-independent pathways of programmed cell death: the unraveling of new targets of cancer therapy? Curr Cancer Drug Targets 9:717–728
Martínez-Poveda B, Muñoz-Chápuli R, Rodríguez-Nieto S, Quintela JM, Fernández A, Medina MA, Quesada AR (2007) IB05204, a dichloropyridodithienotriazine, inhibits angiogenesis in vitro and in vivo. Mol Cancer Ther 6:2675–2685
Cárdenas C, Quesada AR, Medina MA (2004) Effects of ursolic acid on different steps of the angiogenic process. Biochem Biophys Res Commun 320:402–408
Huang SS, Zheng RL (2006) Rosmarinic acid inhibits angiogenesis and its mechanism of action in vitro. Cancer Lett 239:271–280
Kim JH, Lee BJ, Kim JH, Yu YS, Kim MY, Kim KW (2009) Rosmarinic acid suppresses retinal neovascularization via cell cycle arrest with increase of p21(WAF1) expression. Eur J Pharmacol 615:150–154
Muñoz-Chápuli R, Quesada AR, Medina MA (2004) Angiogenesis and signal transduction in endothelial cells. Cell Mol Life Sci 61:2224–2243
Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141:52–67
Fang J, Shing Y, Wiederschain D, Yan L, Butterfield C, Jackson G et al (2000) Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci USA 97:3884–3889
Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S (1998) Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58:1048–1051
Philip S, Kundu GC (2003) Osteopontin induces nuclear factor kappaB-mediated promatrix metalloproteinase-2 activation through I kappa B alpha/IKK signalling pathways, and curcumin (diferulolylmethane) down-regulates these pathways. J Biol Chem 278:14487–14497
Elkin M, Miao HQ, Nagler A, Aingorn E, Reich R, Hemo I et al (2000) Halofuginone: a potent inhibitor of critical steps in angiogenesis progression. FASEB J 14:2477–2485
Acknowledgments
Melissa García is recipient of a predoctoral FPU grant from the Spanish Ministry of Science and Innovation. Authors are indebted to Ramón Muñoz-Chápuli for his helpful advices in the CAM assay and to Cristina Zafra for her preliminary works with rosemary compounds. This work was supported by grants PS09/02216 and TRACE PT2008-0145 (Spanish Ministry of Science and Innovation, ISCIII and FEDER), Fundación Ramón Areces and PIE CTS-3759 (Andalusian Government and FEDER). The “CIBER de Enfermedades Raras” is an initiative from the ISCIII (Spain). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Conflict of interest
The authors state no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Auxiliadora López-Jiménez and Melissa García-Caballero contributed equally to this work.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
López-Jiménez, A., García-Caballero, M., Medina, M.Á. et al. Anti-angiogenic properties of carnosol and carnosic acid, two major dietary compounds from rosemary. Eur J Nutr 52, 85–95 (2013). https://doi.org/10.1007/s00394-011-0289-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00394-011-0289-x